Adenovirus-mediated suicide gene transduction: Feasibility in lens epithelium and in prevention of posterior capsule opacification in rabbits

Human Gene Therapy

Volumn 10, Issue 14, 1999, Pages 2365-2372

  Malecaze, François ^a   Couderc, Bettina ^b   De Neuville, Sylvie ^a   Serres, Brigitte ^a   Mallet, Jacques ^c   Douin Echinard, Victorine ^b   Manenti, Stéphane ^a   Revah, Frédéric ^d   Darbon, Jean Marie ^a  

^a CHU PURPAN   (France)

^b INSTITUT CLAUDIUS REGAUD   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CATARACT; CONTROLLED STUDY; EPITHELIUM CELL; ESCHERICHIA COLI; GENE TRANSFER; GENETIC TRANSDUCTION; LENS; NONHUMAN; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATION; RABBIT; SUICIDE GENE; VIRUS INFECTION;

ADENOVIRIDAE; ANIMALS; ANTIVIRAL AGENTS; BETA-GALACTOSIDASE; CATARACT; EPITHELIAL CELLS; FEASIBILITY STUDIES; GANCICLOVIR; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HYPERPLASIA; LENS CAPSULE, CRYSTALLINE; MICROSCOPY, PHASE-CONTRAST; PHACOEMULSIFICATION; RABBITS; SIMPLEXVIRUS; THYMIDINE KINASE;

ADENOVIRIDAE; ANIMALIA; ESCHERICHIA COLI; HERPES; ORYCTOLAGUS CUNICULUS; SIMPLEXVIRUS;

EID: 0033588964     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950017013     Document Type: Article

References (34)

1. ABRAHAM, N., DA SILVA, J.L., LAVROUSKY, Y., STOLTZ, R.A., KAPPAS, A., DUNN, M., and SCHWARTZMAN, M.L. (1995). Adenovirus-mediated heme oxygenase-1 gene transfer into rabbit ocular tissues. Invest. Ophthalmol. Vis. Sci. 36, 2202-2210.
2. APPLE, D.J., SOLOMON, K.D., TETZ, M.R., ASSIA, E.I., HOLLAND, E.Y., LEGLER, U.F., TSAI, J.C., CASTANEDA, V.E., HOGGATT, J.P., and KOSTICK, A.M. (1992). Posterior capsule opacification. Surv. Ophthalmol. 37, 73-116.
3. BENNETT, J., WLISON, J., SUN, D., FORBES, B., and MAGUIRE, A. (1994). Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest. Ophthalmol. Vis. Sci. 35, 2535-2542.
4. BORRAS, T., TAMM, E.R., and ZIGLER, J.S. (1995). Ocular adenovirus gene transfer varies in efficiency and inflammatory response. Invest. Ophthalmol. Vis. Sci. 87, 1282-1293.
5. BUDENZ, D., BENNETT, J., ALONSO, L., and MAGUIRE, A. (1995). In vivo gene transfer into murine corneal endothelial and trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 36, 2211-2215.
6. COUDERC, B.C., DE NEUVILLE, S., DOUIN-ECHINARD, V., SERRES, B., MANENTI, S., DARBON, J.-M., and MALECAZE, F. (1999). Retrovirus-mediated transfer of a suicide gene into lens epithelial cells in vitro and in an experimental model of posterior capsule opacification. Curr. Eye Res. (in press).
7. DEDIEU, J.F., VIGNE, E., TORRENT-JULLIEN, C., MAHFOUZ, I., CAILLAUD, J.M., AUBAILLY, N., ORSINI, C., GUILLAUME, J.M., OPOLON, P., DELABRE, P., PERRICAUDET, M., and YEH, P. (1998). Long term gene delivery into the livers of immunocompetent mice with E1/E4 defective adenoviruses. J. Virol. 71, 4626-4637.
8. GOODENOUGH, D.A. (1979). Lens gap junctions: A structural hypothesis for nonregulated low-resistance intercellular pathways. Invest. Ophthalmol. Vis. Sci. 18, 1104-1122.
9. GREEN, W.R., and McDONNEL, P.J. (1985). Opacification of the posterior capsule. Trans. Ophthalmol. Soc. U.K. 104, 727-739.
10. HANSEN, S.O., SOLOMON, K.D., McKNIGHT, G.T., WILBRANDT, T.H., GWIN, T.D., O'MORCHOE, D.J.C., TETZ, M.R., and APPLE, D.J. (1988). Posterior capsule opacification and intraocular lens decentration. I. Comparison of various posterior chamber lens designs implanted in the rabbit model. J. Cataract Refract. Surg. 14, 605-613.
11. HEPSEN, I.E., BAYRAMALAR, H., GULKET, A., OZEN, S., TILGEN, F., and EVEREKLIOGLU, C. (1997). Caffeic acid phenethylester to inhibit posterior capsule opacification in rabbits. J. Cataract Refract. Surg. 23, 1572-1576.
12. HODGE, W.G. (1998). Posterior capsule opacification after cataract surgery. Ophthalmology 105, 943-944.
13. HURWITZ, M.Y., MARCUS, K.T., CHEVEZ-BARRIOS, P., LOUIE, K.E., AGUILAR-CORDOVA, E., and HURWITZ, R.L. (1999). Suicide gene therapy for treatment of retinoblastoma in a murine model. Hum. Gene Ther. 10, 441-448.
14. KIT, S. (1985). Thymidine kinase. Microbiol. Sci. 2, 369-375.
15. LIEBER, A., YCHY, H., KIRILLOVA, I., and KAY, M.A. (1996). Recombinant adenoviruses large deletions generated by cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo. J. Virol. 70, 8944-8960.
16. LUNGDREN, B., JONSSON, E., and ROFSEN, W. (1992). Secondary cataract: An in vivo model for studies on secondary cataract in rabbits. Acta Ophthalmol. Suppl. 205, 25-28.
17. MASHHOUR, B., COUTON, D., PERRICAUD, M., and BRIAND, P. (1994). In vivo adenovirus-mediated gene transfer into ocular tissues. Gene Ther. 2, 122-126.
18. MIRZA, M.A., and WEBER, J. (1979). Uncoating of adenovirus type 2. J. Virol. 30, 462-471.
19. MOOLTEN, F.L. (1986). Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res. 50, 7820-7825.
20. MURATA, T., KIMURA, H., SAKAMOTO, T., OSUSKY, R., SPEE, C., STOUT, T.J., HINTON, D.R., and RYAN, S.J. (1997). Ocular gene therapy: Experimental studies and clinical possibilities. Ophthal. Res. 29, 242-251.
21. NISHI, O. (1999) Posterior capsule opacification. J. Cataract Refract. Surg. 25, 106-117.
22. NUSSENBLATT, R.B., and CSAKY, K. (1997). Perspectives on gene therapy in the treatment of ocular inflammation. Eye 11, 217-221.
23. ODRICH, M.G., HALL, S.J., WORGUL, B.V., TROKEL, S.L., and RINI, F.J. (1985). Posterior capsule opacification: Experimental analyses. Ophthal. Res. 17. 75-84.
24. OHADI, C., MOREIRA, H., and McDONNELL, P. (1991). Posterior capsule opacification. Curr. Opin. Ophthalmol. 2, 46-52.
25. PAPANICOLAOU, G.N. (1954). Atlas of Exfoliative Cytology. Techniques. (Harvard University Press, Cambridge) pp. 3-12.
26. PEPOSE, J.S., and LEIB, D.A. (1994). Herpes simplex viral vectors for therapeutic gene delivery to ocular tissues: Recent breakthroughs in the molecular genetics of ocular diseases. Invest. Ophthalmol. Vis. Sci. 35, 2662-2666.
27. EDDAN, J.R., MISRA, I.C., and DZIEDZIC, D.C. (1995). Establisbment of epithelial lines from cryopreserved lenses and capsule-epithelial preparations. Invest. Ophthalmol. Vis. Sci. 36, 509-513.
28. ROSS, G., ERICKSON, R., KNORR, D., MOTULSKY, A.C., PARKMAN, R., SAMULSI, J., STRAUSS, S.E., and SMITH, B.R. (1996). Gene therapy in the United States: A five years status report. Hum. Gene Ther. 7, 1781-1790.
29. TSUBOTA, K., INOUE, H., ANDO, K., ONO, M., YOSHINO, K., and SAITO, I. (1998). Adenovirus-mediated gene transfer to the ocular surface epithelium. Exp. Eye Res. 67, 531-538.
30. VIGNE, E., DEDIEU, J.F., ORSINI, C., LATTA, M., KLONJKOWSKI, B., PROST, E., LAKICH, M., KREMER, E., DENEFLE, P., PERRICAUDET, M., and YEH, P. (1996). Improvements of adenoviral vectors for human gene therapy. In Genetic Approaches to Noncommunicable Diseases. K. Berg, V. Boulyenkov, and Y. Christen, eds. (Springer-Verlag, Berlin) pp. 113-131.
31. WANG, Q., and FINER, M.H. (1996). Second-generation adenovirus vectors. Nature Med. 2, 714-716.
32. WICKSTRÖM, K., ANDERSON, N., JOHANSSON, B., ROLFSEN, W., TÖRNGENVON, L., MALMBORG, A., and LUNDGREN, B. (1996). Rabbit and monkey lens epithelial cell (Lee) proliferation after lens extraction and 5-fluorouracil (5-FU) administration. Invest. Ophthalmol. Vis. Sci. 37 (Suppl.), S765.
33. WRIGHT, A.F. (1997). Gene therapy for the eye. Br. J. Ophthalmol. 81, 620-623.
34. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GÖNCZOL, E., and WILSON, J.M. (1994). Cellular immunity to viral antigens limits E1-detected adenoviruses for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 91, 4407-4411.